A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
-
Ljungman, Per (Karolinska Institutet (Estocolm, Suècia))
;
Bermúdez, Arancha (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ;
Logan, Aaron C. (Division of Hematology and Blood and Marrow Transplantation. Department of Medicine. University of California) ;
Kharfan-Dabaja, Mohamed A. (Department of Blood and Marrow Transplantation. H. Lee Moffitt Cancer Center and Research Institute and University of South Florida) ;
Chevallier, Patrice (Service d'Hématologie Clinique. CHU de Nantes. 44093. Nantes. France and CRCINA / INSERM UMR1232 / CNRS ERL6001 IRS UN - 8) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Wulf, Gerald (Department of Hematology and Medical Oncology. University Medical Center Göttingen) ;
Selleslag, Dominik (Department of Hematology. AZ Sint-Jan Brugge-Oostende) ;
Kakihana, Kazuhiko (Hematology Division. Tokyo Metropolitan Komagome Hospital) ;
Langston, Amelia (Winship Cancer Institute. Emory University) ;
Lee, Dong-Gun. (Catholic University of Korea) ;
Solano, Carlos (Instituto de Investigación Sanitaria INCLIVA (València, Comunitat Valenciana)) ;
Okamoto, Shinichiro (Division of Hematology. Department of Medicine. Kelo University School of Medicine) ;
Smith, Larry R. (Vical) ;
Boeckh, Michael (Vaccine and Infectious Disease Division. Fred Hutchinson Cancer Research Center and University of Washington) ;
Wingard, John Reid (Division of Hematology & Oncology. Department of Medicine. University of Florida) ;
Cywin, Beth (Astellas Pharma Global Development) ;
Fredericks, Christine (Astellas Pharma Global Development) ;
Lademacher, Christopher (Astellas Pharma Global Development) ;
Wang, Xuegong (Astellas Pharma Global Development) ;
Young, James (Astellas Pharma Global Development) ;
Maertens, Johan (K.U. Leuven and Department of Hematology)
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
